Loading...

Commercial And Industrial Expansion And Retrofit Demand Will Fuel Opportunity

Published
22 Aug 24
Updated
08 Oct 25
AnalystConsensusTarget's Fair Value
US$452.58
2.5% undervalued intrinsic discount
08 Oct
US$441.29
Loading
1Y
8.0%
7D
1.2%

Author's Valuation

US$452.582.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 Oct 25
Fair value Increased 1.29%

Narrative Update on TopBuild: Analyst Price Target Revision Analysts have raised their fair value estimate for TopBuild from $446.83 to $452.58, citing slightly improved revenue growth projections despite marginal shifts in other key metrics. What's in the News TopBuild will host an Analyst/Investor Day to discuss its business model, growth drivers, capital allocation strategy, and long-term financial targets.

Shared on07 Aug 25
Fair value Increased 4.71%

With no changes observed in TopBuild's discount rate or future P/E, there is no substantive adjustment to valuation, and the consensus Analyst Price Target remains steady at $426.75. What's in the News Completed repurchase of 545,289 shares (1.9%) for $163.58 million under announced buyback plan.

Shared on07 May 25
Fair value Increased 17%

Shared on30 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 1.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 3.23%

AnalystConsensusTarget has decreased revenue growth from 1.6% to 1.1%.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.75%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 1.79%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 2.05%

AnalystConsensusTarget has decreased revenue growth from 3.6% to 1.5% and decreased future PE multiple from 19.3x to 16.7x.